← Back

IPercept πŸ‡ΈπŸ‡ͺ

Series A Β· $16.5M

Stockholm diagnostic devices predicting CNC machine failures

About IPercept

IPercept offers a CNC machine monitoring software that provides insights into machine wear, misalignment, and degradation trends, enabling proactive maintenance and operational efficiency. The technology utilizes advanced data analytics to deliver actionable insights that enhance productivity and reduce unplanned downtime across various machine brands and controller types.

IPercept is a Sweden-based company founded in 2019, now around 26 people. It has raised $16.5M in disclosed funding. FundFinder classes it as Health & Bio.

Founded by Andreas Archenti (Founder and CSO; repeat founder; previously Archentec, Volvo Cars; KTH Royal Institute of Technology), Karoly Szipka (Founder & CEO; repeat founder; previously ASIMA - Automated Side and Interior Mirror Adjustment System, Start-Up, C3D Engineering Consultant LTD.; Budapest University of Technology and Economics), Christian Nordberg (Head Of Partner Success, Co-Founder; previously Blowpoint, Business Consultant; University of Gothenburg), Peter Troll (Head of AI, Co-founder; previously AUDI HUNGARIA Zrt., John Templeton Foundation; Budapest University of Technology and Economics).

Its investors also appear on FundFinder's most-active lists for Series A Β· B2B (80 funds), Series A Β· AI (62 funds), Series A Β· Climate & Sustainability (53 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on IPercept? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series A Β· $16.5M Β· Sep 2026

Investors2150
  • 2150 β€” Capital for tech entrepreneurs who make urban environments more efficient and sustainable Β· cheques Β£1M – Β£7M

Read the announcement β†—

Raising your own round? See which European funds fit β†’